Guobang Pharma Ltd (605507) — Net Asset Quality Index
Guobang Pharma Ltd (605507) has a Net Asset Quality Index of 76.5% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥11.40 Billion minus total liabilities of CN¥2.68 Billion yields net assets of CN¥8.72 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See operational self-sufficiency of Guobang Pharma Ltd to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Guobang Pharma Ltd Net Asset Quality Index Over Time (2017–2025)
This chart shows how Guobang Pharma Ltd's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the index stands at 76.5%, representing net assets of CN¥8.72 Billion against total assets of CN¥11.40 Billion CNY. Explore Guobang Pharma Ltd (605507) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Guobang Pharma Ltd (2017–2025)
The table below presents the year-by-year Net Asset Quality Index for Guobang Pharma Ltd from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 605507 market cap overview.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 77.9% | CN¥8.56 Billion | CN¥10.98 Billion | CN¥2.43 Billion | ▲ +3.2 pp |
| 2024 | 74.7% | CN¥8.05 Billion | CN¥10.78 Billion | CN¥2.73 Billion | ▲ +2.9 pp |
| 2023 | 71.8% | CN¥7.44 Billion | CN¥10.36 Billion | CN¥2.92 Billion | ▼ -7.3 pp |
| 2022 | 79.1% | CN¥7.15 Billion | CN¥9.04 Billion | CN¥1.89 Billion | ▼ -5.3 pp |
| 2021 | 84.5% | CN¥6.35 Billion | CN¥7.51 Billion | CN¥1.17 Billion | ▲ +25.0 pp |
| 2020 | 59.4% | CN¥3.27 Billion | CN¥5.51 Billion | CN¥2.23 Billion | ▲ +4.5 pp |
| 2019 | 55.0% | CN¥2.62 Billion | CN¥4.76 Billion | CN¥2.14 Billion | ▼ -4.4 pp |
| 2018 | 59.4% | CN¥2.59 Billion | CN¥4.37 Billion | CN¥1.77 Billion | ▲ +4.5 pp |
| 2017 | 54.9% | CN¥2.21 Billion | CN¥4.02 Billion | CN¥1.82 Billion | — |